UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of October 2022 (Report No. 4)
Commission file number: 001-39957
NLS PHARMACEUTICS LTD.
(Translation of registrant’s name into English)
The Circle 6
8058 Zurich, Switzerland
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulations S-T Rule 101(b)(1):_____
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulations S-T Rule 101(b)(7):_____
CONTENTS
This
Report of Foreign Private Issuer on Form 6-K consists of (i) NLS Pharmaceutics Ltd.’s, or the Registrant’s, Condensed Financial
Statements (unaudited) as of June 30, 2022, which is attached hereto as Exhibit 99.1; and (iii) the Registrant’s Management’s
Discussion and Analysis of Financial Condition and Results of Operations for the six months ended June 30, 2022, which is attached hereto
as Exhibit 99.2.
This report on Form 6-K is incorporated by reference into the Registrant’s Registration Statement on Form
F-3 (File No. 333-262489), filed with the Securities and Exchange Commission, to be a part thereof from the date on which this
report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
NLS Pharmaceutics Ltd. |
|
|
|
Date: October 11, 2022 |
By: |
/s/ Alexander Zwyer |
|
|
Name: |
Alexander Zwyer |
|
|
Title: |
Chief Executive Officer |
NLS Pharmaceutics Ltd.
false
--12-31
Q2
2022
2022-06-30
0001783036
0001783036
2022-01-01
2022-06-30
0001783036
2022-06-30
0001783036
2021-12-31
0001783036
2022-01-02
2022-06-30
0001783036
2021-01-02
2021-06-30
0001783036
us-gaap:CommonStockMember
2021-12-31
0001783036
us-gaap:TreasuryStockMember
2021-12-31
0001783036
us-gaap:AdditionalPaidInCapitalMember
2021-12-31
0001783036
us-gaap:RetainedEarningsMember
2021-12-31
0001783036
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-12-31
0001783036
us-gaap:CommonStockMember
2022-01-01
2022-06-30
0001783036
us-gaap:TreasuryStockMember
2022-01-01
2022-06-30
0001783036
us-gaap:AdditionalPaidInCapitalMember
2022-01-01
2022-06-30
0001783036
us-gaap:RetainedEarningsMember
2022-01-01
2022-06-30
0001783036
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-01-01
2022-06-30
0001783036
us-gaap:CommonStockMember
2022-06-30
0001783036
us-gaap:TreasuryStockMember
2022-06-30
0001783036
us-gaap:AdditionalPaidInCapitalMember
2022-06-30
0001783036
us-gaap:RetainedEarningsMember
2022-06-30
0001783036
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-06-30
0001783036
us-gaap:CommonStockMember
2020-12-31
0001783036
us-gaap:AdditionalPaidInCapitalMember
2020-12-31
0001783036
us-gaap:RetainedEarningsMember
2020-12-31
0001783036
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-12-31
0001783036
2020-12-31
0001783036
us-gaap:CommonStockMember
2021-01-01
2021-06-30
0001783036
us-gaap:AdditionalPaidInCapitalMember
2021-01-01
2021-06-30
0001783036
us-gaap:RetainedEarningsMember
2021-01-01
2021-06-30
0001783036
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-01-01
2021-06-30
0001783036
2021-01-01
2021-06-30
0001783036
us-gaap:CommonStockMember
2021-06-30
0001783036
us-gaap:AdditionalPaidInCapitalMember
2021-06-30
0001783036
us-gaap:RetainedEarningsMember
2021-06-30
0001783036
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-06-30
0001783036
2021-06-30
0001783036
2021-01-01
0001783036
2021-02-02
2021-02-02
0001783036
2021-02-02
0001783036
nlsp:BackgroundMember
2021-02-02
0001783036
nlsp:GoingConcernMember
2022-01-01
2022-06-30
0001783036
us-gaap:FurnitureAndFixturesMember
2022-01-01
2022-06-30
0001783036
us-gaap:SoftwareDevelopmentMember
2022-01-01
2022-06-30
0001783036
2021-01-01
2021-12-31
0001783036
us-gaap:FurnitureAndFixturesMember
2022-06-30
0001783036
us-gaap:FurnitureAndFixturesMember
2021-12-31
0001783036
us-gaap:SoftwareDevelopmentMember
2022-06-30
0001783036
us-gaap:SoftwareDevelopmentMember
2021-12-31
0001783036
2022-01-31
0001783036
2021-03-01
2021-03-10
0001783036
2022-04-25
0001783036
2022-03-01
2022-03-05
0001783036
2022-03-31
0001783036
2022-03-01
2022-03-31
0001783036
2022-04-01
2022-04-13
0001783036
us-gaap:WarrantMember
2022-04-25
0001783036
us-gaap:WarrantMember
2022-04-01
2022-04-25
0001783036
2021-12-01
2021-12-14
0001783036
2019-10-31
0001783036
2019-10-01
2019-10-31
0001783036
nlsp:ConsultingAgreementMember
2022-01-01
2022-06-30
0001783036
nlsp:ConsultingAgreementMember
2021-01-01
2021-06-30
0001783036
nlsp:CHGBioVentureSAMember
2020-10-31
0001783036
nlsp:CHGBioVentureSAMember
2020-10-01
2020-10-31
0001783036
nlsp:CHGBioVentureSAMember
2022-01-01
2022-06-30
0001783036
nlsp:CHGBioVentureSAMember
2021-01-01
2021-06-30
0001783036
nlsp:MrRoyMember
2021-03-01
2021-03-31
0001783036
nlsp:MrRoyMember
2022-01-01
2022-06-30
0001783036
nlsp:MrRoyMember
2021-01-01
2021-06-30
0001783036
nlsp:MrKonofalMember
2021-02-01
2021-02-28
0001783036
nlsp:MrKonofalMember
2022-01-01
2022-06-30
0001783036
nlsp:MrKonofalMember
2021-01-01
2021-06-30
0001783036
nlsp:MrCamozziMember
2021-03-01
2021-03-31
0001783036
nlsp:MrCamozziMember
2022-01-01
2022-06-30
0001783036
nlsp:MrCamozziMember
2021-01-01
2021-06-30
0001783036
nlsp:MrHellmannMember
2022-06-30
0001783036
nlsp:MrHellmannMember
2022-01-01
2022-06-30
0001783036
2022-07-21
0001783036
2022-08-19
2022-08-19
0001783036
2022-08-19
0001783036
2022-09-30
iso4217:USD
iso4217:CHF
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:shares
xbrli:pure
iso4217:CHF